Quantcast
Home > Quotes > DYAI

Dyadic International, Inc. Common Stock (DYAI) Quote & Summary Data

DYAI 
$5.13
*  
0.04
0.79%
Get DYAI Alerts
*Delayed - data as of Jul. 22, 2019 13:24 ET  -  Find a broker to begin trading DYAI now
Exchange:NASDAQ
Industry: Basic Industries
Community Rating:
View:    DYAI Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 5.10 / $ 5.14
1 Year Target
8
Today's High / Low
$ 5.20 / $ 5.06
Share Volume
21,412
50 Day Avg. Daily Volume
168,632
Previous Close
$ 5.09
52 Week High / Low
$ 7.30 / $ 3.03
Market Cap
137,296,683
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
21,412
50 Day Avg. Daily Volume:
168,632

Trading Range

The current last sale of $5.13 is 69.31% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 5.20 $ 7.30
 Low: $ 5.06 $ 3.03

Company Description (as filed with the SEC)

Dyadic International, Inc. ("Dyadic", "we", or the "Company") is a global biotechnology platform company based in Jupiter, Florida with operations in the United States, a satellite office in the Netherlands and research organizations performing services under contract to Dyadic in Finland and Spain. Over the past two decades, the Company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has previously licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Myceliophthora thermophila fungus, which the Company named C1. The C1 technology is a robust and versatile fungal expression system for the development and production of enzymes and other proteins.  ... More ...  



Risk Grade

Where does DYAI fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 5.08
Open Date:
Jul. 22, 2019
Close Price:
$ 5.09
Close Date:
Jul. 19, 2019


Consensus Recommendation

Analyst Info